PET Study in a Patient with Spinocerebellar Degeneration before and after Long-Term Administration of Thyrotropin Releasing Hormone
We studied the chronic effect of thyrotropin releasing hormone (TRH) in a patient with spinocerebellar degeneration by measuring cerebral metabolic rate for glucose (CMRG1c) using 2-[18F]fluoro-2-deoxy-D-glucose (18FDG) and positron emission tomography (PET). A 56-year-old female, who had suffered f...
Saved in:
Main Authors: | H. Tanji, H. Nagasawa, T. Hayashi, H. Onodera, T. Fujiwara, M. Itoh, T. Ido, Y. Itoyama |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1996-01-01
|
Series: | Behavioural Neurology |
Online Access: | http://dx.doi.org/10.3233/BEN-1996-93-409 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Contribution of the Cerebellum to Cognition in Spinocerebellar Ataxia Type 6
by: Freya E. Cooper, et al.
Published: (2010-01-01) -
Clinical-cognitive Characterization of Spinocerebellar Ataxia Type 2
by: Alberto Caballero Laguna, et al.
Published: (2021-09-01) -
Depression and Associated Factors Among Patients with Spinocerebellar Ataxia
by: Sirivipa Jekpoo, et al.
Published: (2025-01-01) -
Simultaneous Coexistence of Thyrotropin-Prolactin-Secreting Adenoma and Papillary Thyroid Carcinoma
by: Somaya Safi, et al.
Published: (2021-01-01) -
Erratum to “A Preliminary Characterisation of Cognition and Social Cognition in Spinocerebellar Ataxia Types 2, 1, and 7”
by: N. Sokolovsky, et al.
Published: (2010-01-01)